| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.83B | 18.70B | 19.14B | 18.62B | 18.42B | 19.53B |
| Gross Profit | 4.20B | 4.16B | 4.18B | 3.56B | 4.02B | 4.41B |
| EBITDA | 1.44B | 1.45B | 1.75B | 1.27B | 1.83B | 1.78B |
| Net Income | 279.82M | 319.61M | 495.37M | 232.90M | 540.08M | 581.69M |
Balance Sheet | ||||||
| Total Assets | 20.81B | 20.66B | 23.01B | 21.67B | 21.56B | 21.82B |
| Cash, Cash Equivalents and Short-Term Investments | 3.07B | 3.08B | 3.45B | 3.18B | 3.31B | 3.26B |
| Total Debt | 3.96B | 3.64B | 4.51B | 4.64B | 4.91B | 5.42B |
| Total Liabilities | 8.93B | 8.80B | 10.29B | 10.09B | 10.25B | 11.06B |
| Stockholders Equity | 11.86B | 11.84B | 11.90B | 10.82B | 10.44B | 9.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 538.51M | 825.20M | 387.89M | 648.74M | -319.17M |
| Operating Cash Flow | 0.00 | 1.01B | 1.37B | 822.56M | 1.75B | 1.47B |
| Investing Cash Flow | 0.00 | -1.41B | -742.14M | -432.40M | -996.83M | -1.84B |
| Financing Cash Flow | 0.00 | -63.52M | -385.96M | -562.37M | -797.09M | -138.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥44.53B | 14.40 | ― | 1.51% | 5.86% | 57.87% | |
75 Outperform | ¥33.23B | 13.70 | ― | 1.23% | 6.74% | 29.20% | |
72 Outperform | ¥79.76B | 15.26 | ― | 1.55% | 5.78% | 14.23% | |
69 Neutral | ¥63.43B | 17.77 | ― | 4.63% | 7.74% | 0.96% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | ¥8.41B | 22.89 | ― | 2.12% | 0.45% | -50.91% | |
49 Neutral | ¥63.92B | 32.01 | ― | 1.14% | 8.17% | 10.65% |